Home MarketAddlife Pharma Ltd.

Addlife Pharma Ltd. Stock Info: As on 2004-05-18 00:00:00




Change %
52 Week Range
Day's Range0.00 - 0.00
Value Traded (in ₹ Cr.) 0.00

Stock Exchange

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 0.00
Basic EPS (Rs.) 0.00
Cash EPS 0.00
BVPerShare Excl 0.00
Operating Revenue 0.00
PBDITPerShare 0.00
Dividend 0.00
NPPerShare 0.00
Current Ratio 0.00
Quick Ratio 0.00
PriceToBV 0.00
Earnings 0.00
PBDIT Margin 0.00
PBT Margin 0.00
NP Margin 0.00
Return On Assets 0.00
Retention Ratios 0.00
Total Assets
Total Assets

Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

629.95 624.05 0.95

Abbott India Ltd.

5650 5686.15 -0.64

Ajanta Pharma Ltd.

1336.95 1350.35 -0.99

Albert David Ltd.

371.5 371 0.13

Alembic Ltd.

60.8 60.6 0.33

Alembic Pharmaceuticals Ltd.

571.5 554.8 3.01

Alkem Laboratories Ltd.

2179.95 2158.65 0.99
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

50.45 51.25 -1.56

Aarti Drugs Ltd.

633.7 626.9 1.08

Aayush Food & Herbs Ltd.

64.95 64.4 0.85

Abbott India Ltd.

5675.15 5667.4 0.14

ABL Bio-Technologies Ltd.

0.81 0.78 3.85

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23

Advik Laboratories Ltd.

5.68 5.61 1.25

Stock Held By Mutual Fund Schemes

Sebi revokes curbs on Sanco Industries

Markets regulator Sebi has lifted the curbs imposed on Sanco Industries, which was among the suspected shell companies, after finding no prima facie evidence of misrepresentation of financials by the company. ...I do not find any prima facie evidence nor suspicion of misrepresentation of financials/ business by the company (Sanco Industries), misuse of books of accounts/ funds of the company or violation of LODR (Listing Obligations and Disclosure Requirements) Regulations, Sebi Whole Time Member Madhabi Puri Buch said in an order dated February 15. Buch also said that she is of the considered view that the actions envisaged in Sebi's letter dated August 7, 2017 against Sanco Industries are liable to be revoked. Sanco Industries was among the firms against whom the Securities and Exchange Board of India (Sebi) initiated action on August 7 by ordering trading restrictions, following receipt of a list of 331 'suspected shell companies' from the government. The ordered trade restrictions - allowing trade only once a month and that too for only buy transactions with a 200 per cent security deposit - were revoked in some cases a few days later following appeals filed by them with the Securities Appellate Tribunal, but Sebi was asked to continue with its probe and pass its orders expeditiously.

20-02-2018 10:04

Promoter buys stake worth Rs 111 cr in KEC Intl

KEC International's promoter Instant Holdings today bought over 1 per cent stake in the infrastructure major for Rs 111 crore through an open market transaction. According to the block deal data available with the BSE, the promoter purchased 28.05 lakh shares, amounting to 1.09 per cent stake in the firm. The shares were acquired at an average price of Rs 395.95, valuing the transaction at Rs 111.07 crore, the data showed. At the end of the December 2017 quarter, Instant Holdings held 1.80 crore shares, or 7.01 per cent, in KEC International. The shares were sold by Stellar Energy Trust. In a separate block deal, Instant Holdings disposed of 14.81 per cent stake in the drug firm RPG Life Sciences for Rs 110.94 crore. The data showed that Instant Holdings, a promoter of RPG Life Sciences, offloaded 24.50 lakh shares, or 14.81 per cent, in the drug firm. The shares were sold at a price of Rs 452.85 apiece, translating into a transaction worth Rs 110.94 crore. Instant Holdings controlled 16.53 per cent stake in RPG Life Sciences at the end of December 2017 quarter. The shares were purchased by Nucleus Life Trust. Meanwhile, shares of the company were trading at Rs 384.45 apiece, up 2.11 per cent from the previous close at 10:11 hours on BSE.

20-02-2018 10:04

Prime Focus’ arm bags award for Best Special Visual Effects

Prime Focus has said that its arm Double Negative (DNEG) has been honoured at the BAFTA awards 2018 for its work on ‘Blade Runner 2049’. The film picked up the award for ‘ Best Special Visual Effects ’ at the star - studded ceremony last night. This is the third award that DNEG has won in less than a week , having picked up two Visual Effects Society awards last Tuesday for its work on Denis Villeneuve’s ‘Blade Runner 2049’ and Christopher Nolan’s ‘Dunkirk’. DNEG was the lead Visual Effects house for both films , and is also nominated in the ‘ Best Visual Effects’ category for its work on ‘Blade Runner 2049’ at the 90th Academy Awards on March 4th 2018 in Los Angeles. Led by VFX Supervisor Paul Lambert, DNEG’s Blade Runner team delivered most of the Los Angeles 2049 cityscapes, the Joi hologram effects and the seawall chase at the end of the movie. Meanwhile, shares of the company closed at Rs 101.15 apiece, down 1.27 per cent from the previous close at 10:03 hrs on BSE.

20-02-2018 10:03

IndiGrid completes acquisition of three assets

IndiGrid has said that it has completed the acquisition of three assets - RAPP Transmission Company Limited, Purulia and Kharagpur Transmission Company Limited and Maheshwaram Transmission Limited from its Sponsor- Sterlite Power Grid Ventures Limited . It has simultaneously signed definitive agreements with Techno Electric & Engineering Company Limited to invest in Patran Transmission Company Limited (“PTCL”). The purchase consideration for MRP is INR 14.10 billion and for PTCL is INR 2.32 billion. Both these acquisitions are highly accretive and will increase portfolio IRR to 11% at current price. They will enable IndiGrid to deliver a DPU of at least INR 12 for the next five years . Commenting on the developments, Pratik Agarwal, Chief Executive Officer, IndiGrid , said, “ In line with its vision of reaching an AUM of INR 300 billion, IndiGrid has successfully completed the first set of the acquisition s. Further, we have demonstrated our ability to pursue third party assets by signing definitive agreement s with Techno Electric . The fundamentals of the power transmission sector in India remain robust and IndiGrid will continue to acquire assets from both the Sponsor and third parties to further increase portfolio IRR ” .

20-02-2018 10:00

NTPC pays interim dividend of Rs 2,251 cr to shareholders

State-run power giant NTPC today said it has paid interim dividend of Rs 2,251 crore for 2017-18. For the financial year 2017-18, NTPC Ltd has paid an interim dividend of Rs 2,251.01 crore,being 27.30 per cent of the paid-up equity share capital of the company, an NTPC Ltd statement said. According to the statement, the real-time gross settlement advice for the transfer of Rs 1,401.81 crore, to the Government of India, being its share in the interim dividend, was presented by NTPC CMD Gurdeep Singh to R K Singh, Minister of State for Power and New and Renewable Energy.This is the 25th consecutive year that NTPC has paid dividend, it added. Meanwhile, shares of the company were trading at Rs 163.45 apiece, up 0.28 per cent from the previous close at 10:06 hours on BSE.

20-02-2018 09:57

Corporate Details

About Management

M/s Add-Life Pharma Ltd which was initially incorporated as a private limited company on 11th january 1991, was promoted by Shri Ishwarbhai Patel, Shri Rameshbhai Patel & their associates. Subsequently, it was reorganised with the induction of Dr Bharat I Patel in September, 1992 and the Company was converted into AddLife Pharma Ltd on 17th May, 1993.

Registered Office

412 - 2 / C, Payal Complex Opp Fortune Towers, Sayajigunj

0265-26468503,26468503,,      0265-26400513,

Registrar Details